SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-09-022035
Filing Date
2009-09-30
Accepted
2009-09-30 16:18:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICAL INC 13D A 9-9-2009 formsc13da.htm SC 13D/A 1054297
  Complete submission text file 0001140361-09-022035.txt   1056346
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Subject) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79996 | Film No.: 091095800
SIC: 2834 Pharmaceutical Preparations

Mailing Address 401 WOOYOUNG VENTURE BLDG. SEOCHO-DONG SEOCHO-GU SEOUL M5 1330-13
Business Address 401 WOOYOUNG VENTURE BLDG. SEOCHO-DONG SEOCHO-GU SEOUL M5 1330-13 82-2 587 0019
Rexgene Biotech Co., Ltd. (Filed by) CIK: 0001316425 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13D/A